Current stock page

Financial Data

WAT Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Diagnostics & ResearchScore data as of Sep 4, 2026

WAT

Financial Data
Waters Corporation
Healthcare· Medical - Diagnostics & Research
AIQ Score
NeutralAIQ Edge 4/10
Low Priority
In Line With Peers
Score data as of Sep 4, 2026
Last price
$409.38
-$4.18 (-1.01%)
Latest market quote
Momentum57
Value32
Quality50
Risk Resilience65
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 6, 2026.

Income statement
8 periods
Metric2026-07-042026-04-042025-12-312025-09-272025-06-282025-03-292024-12-312024-09-28
Revenue$1.65B$1.27B$932.36M$799.89M$771.33M$661.71M$872.71M$740.31M
Gross Profit$734M$595M$569.5M$472.08M$449.93M$384.96M$524.2M$438.65M
Operating Income
Net Income-$136M-$72M$225.21M$148.92M$147.11M$121.38M$231.4M$161.5M
EPS-$1.39-$0.87$3.78$2.5$2.47$2.04$3.9$2.72
Cash flow statement
8 periods
Metric2026-07-042026-04-042025-12-312025-09-272025-06-282025-03-292024-12-312024-09-28
Operating Cash Flow$200M-$3M$164.55M$187.31M$41.14M$259.55M$240.14M$204.58M
Capital Expenditure-$49M-$39M-$38.97M-$25.44M-$22.59M-$25.74M-$52.1M-$25.62M
Free Cash Flow$151M-$42M$125.58M$161.87M$18.55M$233.81M$188.04M$178.96M
Net Cash Provided By Operating Activities$200M-$3M$164.55M$187.31M$41.14M$259.55M$240.14M$204.58M
Balance sheet
8 periods
Metric2026-07-042026-04-042025-12-312025-09-272025-06-282025-03-292024-12-312024-09-28
Total Assets$24.75B$24.53B$5.08B$4.86B$4.72B$4.59B$4.55B$4.51B
Total Debt$5.25B$5.57B$0$1.49B$1.54B$1.54B$1.7B$1.9B
Cash And Cash Equivalents
Total Liabilities$9.56B$9.24B$2.52B$2.53B$2.56B$2.63B$2.73B$2.91B
Total Stockholders Equity$15.2B$15.29B$2.56B$2.33B$2.16B$1.96B$1.83B$1.6B
Key financial metrics
8 periods
Metric2026-07-042026-04-042025-12-312025-09-272025-06-282025-03-292024-12-312024-09-28
P/E ratio-68.22-87.4325.1129.1535.6444.3423.832.81
P/B ratio2.451.638.837.459.7110.9712.0513.22
P/S ratio22.6419.7224.2621.7127.1932.5325.2428.63
Debt To Equity0.350.3600.640.710.780.931.19
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-07-042026-04-042025-12-312025-09-272025-06-282025-03-292024-12-312024-09-28
P/E ratio
P/B ratio2.451.638.837.459.7110.9712.0513.22
P/S ratio22.6419.7224.2621.7127.1932.5325.2428.63
Return On Equity-0.90%-0.47%8.79%6.39%6.81%6.19%12.66%10.07%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
100.96
multipleSep 4, 2026
Pb
2.62
multipleSep 4, 2026
Revenue Growth Yoy
29.83
percentSep 4, 2026
EPS Growth Yoy
-59.77
percentSep 4, 2026
Gross Margin
50.78
percentSep 4, 2026
Operating Margin
7.96
percentSep 4, 2026
ROE
1.88
percentSep 4, 2026
ROIC
1.34
percentSep 4, 2026
Debt To Equity
0.35
ratioSep 4, 2026
FCF Yield
1.31
percentSep 4, 2026
Technical indicators
Close
409.38
priceSep 4, 2026
Volume
352,082
volumeSep 4, 2026
Rsi14
51.07
indexSep 4, 2026
MACD
5.93
indexSep 4, 2026
MACD Signal
7.6
indexSep 4, 2026
MACD Histogram
-1.66
indexSep 4, 2026
Adx14
25.01
indexSep 4, 2026
Sma50
391.71
priceSep 4, 2026
Sma200
360.77
priceSep 4, 2026
Atr14
12.42
priceSep 4, 2026
Historical Volatility
0.24
percentSep 4, 2026
Volume Ma20
662,213.95
volumeSep 4, 2026
Risk measures
Resilience Score
65
score_0_100Sep 4, 2026
Beta
1.18
ratioSep 4, 2026
Volatility Annual
36.28
percentSep 4, 2026
Max Drawdown
-31.32
percentSep 4, 2026
Sharpe Ratio
0.94
ratioSep 4, 2026
Var95
-2.85
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

WAT Financial Data FAQ

What is Waters Corporation's revenue?

Waters Corporation's revenue is one of the core financial data points for WAT. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Waters Corporation's revenue growing?

Revenue growth shows whether Waters Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is WAT's EPS?

WAT's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Waters Corporation's net income?

Waters Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Waters Corporation generate?

Free cash flow shows how much cash Waters Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Waters Corporation have?

Cash and debt help frame WAT's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.